According to NICE guideline NG28 , GLP-1 receptor agonists like Ozempic may be considered for adults with type 2 diabetes who have specific criteria, including a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific problems associated with high weight, or a BMI lower than 35 kg/m where insulin would have significant occupational implications or weight loss would benefit other significant obesity-related comorbidities
Your healthcare provider may consider your overall health, medical history, blood sugar levels, weight management goals, medication tolerance, and lifestyle habits before recommending a treatment option
Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms
The messages make it sound urgent to contact them, but it leads to a fraudulent website, according to the BBB
What are suitable antibiotic choices for patients with sulfa allergies?